Pan-European HTA – Where We Have Been, Where We Are Going?

October 4, 2018 Danielle Twigg

EUnetHTA was established in 2005 to create an effective and sustainable network for Health Technology Assessment (HTA) across Europe. EUnetHTA Joint Assessments (JAs) are HTAs produced together by at least four different national European HTA bodies. This research aims to evaluate whether drugs evaluated under EUnetHTA JAs have received better/faster outcomes by participating national European HTA bodies.

Authors: Macaulay R, Campbell J, PAREXEL International, London, United Kingdom

To find out more about this poster you can register to download it here after the ISPOR event.

Previous Article
Are Nice And The SMC Diverging In Their Assessment Of Oncology Drugs?
Are Nice And The SMC Diverging In Their Assessment Of Oncology Drugs?

Next Article
Payer Archetyping – Expanding Horizons
Payer Archetyping – Expanding Horizons